Leading Pharmaceutical Innovation: How to Win the Life Science Race

Forsideomslag
Springer, 10. maj 2018 - 179 sider
0 Anmeldelser
Anmeldelserne verificeres ikke af Google, men Google tjekker indholdet og fjerner det, hvis det er falsk.
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.
 

Hvad folk siger - Skriv en anmeldelse

Vi har ikke fundet nogen anmeldelser de normale steder.

Indhold

Innovation Key to Success in the Pharmaceutical Industry
1
The Industry Challenge Who Would Want to Be in This Business?
17
The Science and Technology Challenge How to Find New Drugs
41
The Pipeline Challenge How to Organize Innovation
63
The MakeorBuy Challenge How to In and Outsource Innovation
79
The Open Innovation Challenge How to Partner for Innovation
111
The Internationalization Challenge Where to Access Innovation
135
Future Directions and Trends
155
Glossary
165
Bibliography
171
Index
177
Copyright

Andre udgaver - Se alle

Almindelige termer og sætninger

Om forfatteren (2018)

Prof. Dr. Oliver Gassmann is professor of technology management at the University of St. Gallen (Switzerland), and managing director of the Institute of Technology Management. After completing his PhD in 1996, he was head of corporate research at Schindler. He published over 400 papers in leading international management journals. In 2014, he was awarded the Scholary Impact Award by the Journal of Management, and in 2015 with the Citation Excellence Award of the Emerald Group. He also serves as a founder and advisor on several boards.

Prof. Dr. Alexander Schuhmacher is professor at Reutlingen University (Germany). He teaches in business management and medical science. He officiates as Senator of Reutlingen University and he also serves as managing director of the Knowledge Foundation @ Reutlingen University. He worked for 14 years in various R&D positions in the pharmaceutical industry. As member of Nycomed’s senior R&D management team, he headed the Strategic Planning & Business Support function and co-headed the R&D integration team following the merger of Nycomed and ALTANA Pharma.

Prof. Dr. Max von Zedtwitz is professor at Kaunas University of Technology (Lithuania), and director of the GLORAD Center for Global R&D and Innovation. Previously he was a professor at Tsinghua, Peking University, Skoltech, and IMD, and a vice president at PRTM. In 2009 he was recognized by IAMOT as one of the fifty most influential innovation scholars worldwide. A frequent public speaker, he has appeared on television, and has been cited in the Economist, China Daily, the South China Morning Post and the New York Times.

Dr. Gerrit Reepmeyer is co-founder & COO of Guardhat Inc., a startup based in Detroit (USA). Prior to that, he held various executive leadership positions in industrial and technology companies. He started his career in management consulting with McKinsey & Company. He has a PhD degree from the University of St. Gallen and was a research scholar at Columbia University in New York. He co-authored several books and publications on technology management, and he is co-inventor of five patents.

Bibliografiske oplysninger